Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Deferred Tax Assets / Liabilities ₹-288 Cr₹122 Cr₹122 Cr₹128 Cr₹98 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA is ₹-288 Cr based on Mar2023 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2023₹-288 Cr
Mar2022₹122 Cr
Mar2021₹122 Cr
Mar2020₹128 Cr
Mar2019₹98 Cr

How is Deferred Tax Assets / Liabilities of AUROBINDO PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2023 ₹-288 Cr
Negative
Mar2022 ₹122 Cr
0.40
Mar2021 ₹122 Cr
-5.14
Mar2020 ₹128 Cr
31.09
Mar2019 ₹98 Cr -

Compare Deferred Tax Assets / Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹67,536.7 Cr 1.9% 3.6% 87.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.9%

3.6%

87.2%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses